We are open as normal during COVID-19 pandemic. Order online, same day shipping out.
WARNING: This product is for research use only, not for human or veterinary use.
DS-3078a is an orally bioavailable inhibitor of raptor-mTOR protein complex (TORC1) and rictor-mTOR protein complex (TORC2) with potential antineoplastic activity. TORC1/2 inhibitor DS-3078a binds to and inhibits both TORC1 and TORC2 , which may result in tumor cell apoptosis and a decrease in tumor cell proliferation. TORC1 and 2 are upregulated in some tumors and play an important role in the PI3K/Akt/mTOR signaling pathway, which is frequently dysregulated in human cancers. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus).
Price and Availability
Pricing updated 2020-07-15.
Prices are subject to change without notice.
DS-3078a is not ready for custom synthesis since we cannot confirm its structure at this moment. We will list structure if it is confirmed from publications.